Bosh sahifaIONS • BMV
add
Ionis Pharmaceuticals Inc
Yopilish kursi
647,00 $
Yillik diapazon
619,00 $ - 900,00 $
Bozor kapitalizatsiyasi
6,84 mlrd USD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 131,61 mln | 10,14% |
Joriy xarajat | 83,55 mln | 39,85% |
Sof foyda | -146,94 mln | -2,90% |
Sof foyda marjasi | -111,64 | 6,58% |
Har bir ulushga tushum | -0,92 | -20,52% |
EBITDA | -144,05 mln | 1,56% |
Amaldagi soliq stavkasi | -0,08% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,15 mlrd | -3,00% |
Jami aktivlari | 2,81 mlrd | 1,77% |
Jami passivlari | 2,34 mlrd | -5,28% |
Umumiy kapital | 475,73 mln | — |
Tarqatilgan aksiyalar | 159,16 mln | — |
Narxi/balansdagi bahosi | 216,39 | — |
Aktivlardan daromad | -12,62% | — |
Kapitaldan daromad | -14,71% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -146,94 mln | -2,90% |
Operatsiyalardan naqd pul | -150,78 mln | -0,56% |
Sarmoyadan naqd pul | 170,46 mln | 123,98% |
Moliyadan naqd pul | 2,20 mln | -90,67% |
Naqd pulning sof oʻzgarishi | 22,12 mln | 143,90% |
Boʻsh pul | -107,97 mln | -16,56% |
Haqida
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Tashkil etilgan
1989
Sayt
Xodimlar soni
1 069
